Microfibrillar cardiomyopathy: An infiltrative heart disease resembling but distinct from cardiac amyloidosis

Stephen M. Factor, Mark A. Menegus, Yvonne Kress, Sangho Cho, John D. Fisher, Lynn Sakai, Sidney Goldfischer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Microfibrils-small, ubiquitous components of the extracellular matrix in many tissues-generally have not been recognized as causing infiltrative heart disease, except in a group of cardiac transplant patients treated with cyclosporin. Microfibrils are often associated with elastic tissue and contain the glycoprotein fibrillin, the P component of amyloid, and bound fibronectin. A genetically determined abnormality of fibrillin caused by point mutations of fibrillin genes recently was reported as the cause of Marfan's syndrome. However, to date, no abnormalities of increased fibrillin tissue deposition have been observed. In the last two years, while examining right ventricular endomyocardial biopsies, in four patients we noted abnormal histology distinct from the usual type of congestive cardiomyopathy but with a strong resemblance to amyloidosis. The patients presented with unexplained ventricular tachycardia (N = 3) and/or congestive heart failure (N = 2). Biopsies revealed subendocardial, interstitial, and perivascular hyaline eosinophilic fibrillar material that did not stain with Congo red. Electron microscopy revealed that this material was organized into bundles of tangled microfibrils composed of twisted and tubular structures measuring up to 17 nm wide, which did not resemble amyloid or cyclosporin-associated microfibrils. Immunoelectron microscopy of the index case, using monoclonal antibody to fibrillin, specifically identified these structures as fibrillin microfibrils; fibronectin also was bound to the interstitial microfibrils. We believe that the subendocardial and interstitial deposition of microfibrils in these four symptomatic patients may represent a new type of infiltrative cardiomyopathy, similar to but distinct from cardiac amyloidosis. We do not know yet if this disorder is genetic or acquired, or if the prognosis is better than that of cardiac amyloidosis. However, atypical cases of primary cardiac amyloidosis should be reevaluated in light of these findings.

Original languageEnglish (US)
Pages (from-to)307-316
Number of pages10
JournalCardiovascular Pathology
Volume1
Issue number4
DOIs
StatePublished - Jan 1 1992

Fingerprint

Microfibrils
Amyloidosis
Cardiomyopathies
Heart Diseases
Fibronectins
Cyclosporine
Serum Amyloid P-Component
Biopsy
Congo Red
Marfan Syndrome
Inborn Genetic Diseases
Hyalin
Elastic Tissue
Immunoelectron Microscopy
Dilated Cardiomyopathy
Ventricular Tachycardia
Point Mutation
Amyloid
Extracellular Matrix
Fibrillins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pathology and Forensic Medicine

Cite this

Microfibrillar cardiomyopathy : An infiltrative heart disease resembling but distinct from cardiac amyloidosis. / Factor, Stephen M.; Menegus, Mark A.; Kress, Yvonne; Cho, Sangho; Fisher, John D.; Sakai, Lynn; Goldfischer, Sidney.

In: Cardiovascular Pathology, Vol. 1, No. 4, 01.01.1992, p. 307-316.

Research output: Contribution to journalArticle

Factor, Stephen M. ; Menegus, Mark A. ; Kress, Yvonne ; Cho, Sangho ; Fisher, John D. ; Sakai, Lynn ; Goldfischer, Sidney. / Microfibrillar cardiomyopathy : An infiltrative heart disease resembling but distinct from cardiac amyloidosis. In: Cardiovascular Pathology. 1992 ; Vol. 1, No. 4. pp. 307-316.
@article{7d77ee4eb0a546e3a19849dbeaae2cb0,
title = "Microfibrillar cardiomyopathy: An infiltrative heart disease resembling but distinct from cardiac amyloidosis",
abstract = "Microfibrils-small, ubiquitous components of the extracellular matrix in many tissues-generally have not been recognized as causing infiltrative heart disease, except in a group of cardiac transplant patients treated with cyclosporin. Microfibrils are often associated with elastic tissue and contain the glycoprotein fibrillin, the P component of amyloid, and bound fibronectin. A genetically determined abnormality of fibrillin caused by point mutations of fibrillin genes recently was reported as the cause of Marfan's syndrome. However, to date, no abnormalities of increased fibrillin tissue deposition have been observed. In the last two years, while examining right ventricular endomyocardial biopsies, in four patients we noted abnormal histology distinct from the usual type of congestive cardiomyopathy but with a strong resemblance to amyloidosis. The patients presented with unexplained ventricular tachycardia (N = 3) and/or congestive heart failure (N = 2). Biopsies revealed subendocardial, interstitial, and perivascular hyaline eosinophilic fibrillar material that did not stain with Congo red. Electron microscopy revealed that this material was organized into bundles of tangled microfibrils composed of twisted and tubular structures measuring up to 17 nm wide, which did not resemble amyloid or cyclosporin-associated microfibrils. Immunoelectron microscopy of the index case, using monoclonal antibody to fibrillin, specifically identified these structures as fibrillin microfibrils; fibronectin also was bound to the interstitial microfibrils. We believe that the subendocardial and interstitial deposition of microfibrils in these four symptomatic patients may represent a new type of infiltrative cardiomyopathy, similar to but distinct from cardiac amyloidosis. We do not know yet if this disorder is genetic or acquired, or if the prognosis is better than that of cardiac amyloidosis. However, atypical cases of primary cardiac amyloidosis should be reevaluated in light of these findings.",
author = "Factor, {Stephen M.} and Menegus, {Mark A.} and Yvonne Kress and Sangho Cho and Fisher, {John D.} and Lynn Sakai and Sidney Goldfischer",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/1054-8807(92)90041-L",
language = "English (US)",
volume = "1",
pages = "307--316",
journal = "Cardiovascular Pathology",
issn = "1054-8807",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Microfibrillar cardiomyopathy

T2 - An infiltrative heart disease resembling but distinct from cardiac amyloidosis

AU - Factor, Stephen M.

AU - Menegus, Mark A.

AU - Kress, Yvonne

AU - Cho, Sangho

AU - Fisher, John D.

AU - Sakai, Lynn

AU - Goldfischer, Sidney

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Microfibrils-small, ubiquitous components of the extracellular matrix in many tissues-generally have not been recognized as causing infiltrative heart disease, except in a group of cardiac transplant patients treated with cyclosporin. Microfibrils are often associated with elastic tissue and contain the glycoprotein fibrillin, the P component of amyloid, and bound fibronectin. A genetically determined abnormality of fibrillin caused by point mutations of fibrillin genes recently was reported as the cause of Marfan's syndrome. However, to date, no abnormalities of increased fibrillin tissue deposition have been observed. In the last two years, while examining right ventricular endomyocardial biopsies, in four patients we noted abnormal histology distinct from the usual type of congestive cardiomyopathy but with a strong resemblance to amyloidosis. The patients presented with unexplained ventricular tachycardia (N = 3) and/or congestive heart failure (N = 2). Biopsies revealed subendocardial, interstitial, and perivascular hyaline eosinophilic fibrillar material that did not stain with Congo red. Electron microscopy revealed that this material was organized into bundles of tangled microfibrils composed of twisted and tubular structures measuring up to 17 nm wide, which did not resemble amyloid or cyclosporin-associated microfibrils. Immunoelectron microscopy of the index case, using monoclonal antibody to fibrillin, specifically identified these structures as fibrillin microfibrils; fibronectin also was bound to the interstitial microfibrils. We believe that the subendocardial and interstitial deposition of microfibrils in these four symptomatic patients may represent a new type of infiltrative cardiomyopathy, similar to but distinct from cardiac amyloidosis. We do not know yet if this disorder is genetic or acquired, or if the prognosis is better than that of cardiac amyloidosis. However, atypical cases of primary cardiac amyloidosis should be reevaluated in light of these findings.

AB - Microfibrils-small, ubiquitous components of the extracellular matrix in many tissues-generally have not been recognized as causing infiltrative heart disease, except in a group of cardiac transplant patients treated with cyclosporin. Microfibrils are often associated with elastic tissue and contain the glycoprotein fibrillin, the P component of amyloid, and bound fibronectin. A genetically determined abnormality of fibrillin caused by point mutations of fibrillin genes recently was reported as the cause of Marfan's syndrome. However, to date, no abnormalities of increased fibrillin tissue deposition have been observed. In the last two years, while examining right ventricular endomyocardial biopsies, in four patients we noted abnormal histology distinct from the usual type of congestive cardiomyopathy but with a strong resemblance to amyloidosis. The patients presented with unexplained ventricular tachycardia (N = 3) and/or congestive heart failure (N = 2). Biopsies revealed subendocardial, interstitial, and perivascular hyaline eosinophilic fibrillar material that did not stain with Congo red. Electron microscopy revealed that this material was organized into bundles of tangled microfibrils composed of twisted and tubular structures measuring up to 17 nm wide, which did not resemble amyloid or cyclosporin-associated microfibrils. Immunoelectron microscopy of the index case, using monoclonal antibody to fibrillin, specifically identified these structures as fibrillin microfibrils; fibronectin also was bound to the interstitial microfibrils. We believe that the subendocardial and interstitial deposition of microfibrils in these four symptomatic patients may represent a new type of infiltrative cardiomyopathy, similar to but distinct from cardiac amyloidosis. We do not know yet if this disorder is genetic or acquired, or if the prognosis is better than that of cardiac amyloidosis. However, atypical cases of primary cardiac amyloidosis should be reevaluated in light of these findings.

UR - http://www.scopus.com/inward/record.url?scp=38249011921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38249011921&partnerID=8YFLogxK

U2 - 10.1016/1054-8807(92)90041-L

DO - 10.1016/1054-8807(92)90041-L

M3 - Article

AN - SCOPUS:38249011921

VL - 1

SP - 307

EP - 316

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

SN - 1054-8807

IS - 4

ER -